Commonwealth Equity Services, LLC Aytu Biopharma, Inc Transaction History

Commonwealth Equity Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.15 - $4.0 $15,000 - $400,000	100,000 Added 47.72%	309,558 $58,000
Q3 2022 Nov 14, 2022	BUY	$0.19 - $3.8 $18,973 - $379,464	99,859 Added 91.03%	209,558 $38,000
Q2 2022 Jul 19, 2022	SELL	$0.46 - $1.08 $39 - $92	-86 Reduced 0.08%	109,699 $75,000
Q1 2022 May 04, 2022	BUY	$1.08 - $1.55 $2,158 - $3,098	1,999 Added 1.85%	109,785 $118,000
Q4 2021 Jan 31, 2022	BUY	$1.35 - $2.95 $91 - $200	68 Added 0.06%	107,786 $145,000
Q3 2021 Oct 29, 2021	BUY	$2.78 - $5.12 $138,777 - $255,590	49,920 Added 86.37%	107,718 $310,000
Q2 2021 Aug 11, 2021	BUY	$4.73 - $7.56 $52,942 - $84,619	11,193 Added 24.02%	57,798 $289,000
Q1 2021 May 04, 2021	BUY	$6.23 - $9.88 $136,443 - $216,381	21,901 Added 88.65%	46,605 $354,000
Q4 2020 Feb 11, 2021	BUY	$5.98 - $13.5 $147,729 - $333,504	24,704 New	24,704 $147,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $102M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.